DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Zelniker TA, Wiviott SD, Raz I. et al
Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus.
Circulation 2019;
139 (17) 2022-2031
DOI: 10.1161/CIRCULATIONAHA.118.038868.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.